Cutler Group LP Aclaris Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 Apr 26, 2021	BUY	$5.86 - $27.73 $12,892 - $61,006	2,200 Added 440.0%	2,700 $1,000
Q3 2020 Oct 27, 2020	SELL	$1.5 - $2.71 $12,000 - $21,680	-8,000 Reduced 94.12%	500 $0
Q3 2019 Oct 28, 2019	SELL	$0.79 - $2.47 $790 - $2,470	-1,000 Reduced 10.53%	8,500 $32,000
Q2 2019 Aug 09, 2019	BUY	$2.13 - $7.06 $18,105 - $60,010	8,500 Added 850.0%	9,500 $29,000
Q4 2018 Feb 05, 2019	BUY	$6.3 - $15.4 $6,300 - $15,400	1,000 New	1,000 $7,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.